{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["hepatotoxicity", "herb induced liver injury", "herbals", "kava", "khat", "kratom"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27092496", "DateCompleted": {"Year": "2017", "Month": "01", "Day": "06"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "04", "Day": "16"}], "ELocationID": ["580", "10.3390/ijms17040580"], "Language": ["eng"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "17", "Issue": "4", "PubDate": {"Year": "2016", "Month": "Apr", "Day": "16"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "Hepatotoxicity Induced by \"the 3Ks\": Kava, Kratom and Khat.", "Pagination": {"StartPage": "580", "MedlinePgn": "580"}, "Abstract": {"AbstractText": ["The 3Ks (kava, kratom and khat) are herbals that can potentially induce liver injuries. On the one hand, growing controversial data have been reported about the hepatotoxicity of kratom, while, on the other hand, even though kava and khat hepatotoxicity has been investigated, the hepatotoxic effects are still not clear. Chronic recreational use of kratom has been associated with rare instances of acute liver injury. Several studies and case reports have suggested that khat is hepatotoxic, leading to deranged liver enzymes and also histopathological evidence of acute hepatocellular degeneration. Numerous reports of severe hepatotoxicity potentially induced by kava have also been highlighted, both in the USA and Europe. The aim of this review is to focus on the different patterns and the mechanisms of hepatotoxicity induced by \"the 3Ks\", while trying to clarify the numerous aspects that still need to be addressed."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Anatomical, Histological, Forensic and Orthopedic Sciences, Sapienza University of Rome, 00161 Rome, Italy. flaminia.pantano@uniroma1.it."}], "LastName": "Pantano", "ForeName": "Flaminia", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Anatomical, Histological, Forensic and Orthopedic Sciences, Sapienza University of Rome, 00161 Rome, Italy. roberta.tittarelli@uniroma1.it."}], "LastName": "Tittarelli", "ForeName": "Roberta", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Anatomical, Histological, Forensic and Orthopedic Sciences, Sapienza University of Rome, 00161 Rome, Italy. giulio.mannocchi@uniroma1.it."}], "LastName": "Mannocchi", "ForeName": "Giulio", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Anatomical, Histological, Forensic and Orthopedic Sciences, Sapienza University of Rome, 00161 Rome, Italy. simona.zaami@uniroma1.it."}], "LastName": "Zaami", "ForeName": "Simona", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Anatomical, Histological, Forensic and Orthopedic Sciences, Sapienza University of Rome, 00161 Rome, Italy. serafino.ricci@uniroma1.it."}], "LastName": "Ricci", "ForeName": "Serafino", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Section of Legal Medicine, Universit\u00e0 Politecnica delle Marche, 60121 Ancona, Italy. r.giorgetti@univpm.it."}], "LastName": "Giorgetti", "ForeName": "Raffaele", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Anatomical, Histological, Forensic and Orthopedic Sciences, Sapienza University of Rome, 00161 Rome, Italy. daniela.terranova@uniroma1.it."}], "LastName": "Terranova", "ForeName": "Daniela", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Anatomical, Histological, Forensic and Orthopedic Sciences, Sapienza University of Rome, 00161 Rome, Italy. fra.busardo@libero.it."}], "LastName": "Busard\u00f2", "ForeName": "Francesco P", "Initials": "FP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Anatomical, Histological, Forensic and Orthopedic Sciences, Sapienza University of Rome, 00161 Rome, Italy. enrico.marinelli@uniroma1.it."}], "LastName": "Marinelli", "ForeName": "Enrico", "Initials": "E"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry"], "DescriptorName": "Catha"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug effects", "pathology"], "DescriptorName": "Liver"}, {"QualifierName": ["chemistry"], "DescriptorName": "Mitragyna"}, {"QualifierName": ["chemistry"], "DescriptorName": "Piper"}, {"QualifierName": ["chemistry", "toxicity"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry", "toxicity"], "DescriptorName": "Plants, Medicinal"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Teschke R., Frenzel C., Glass X., Schulze J., Eickhoff A. Herbal hepatotoxicity: A critical review. Br. J. Clin. Pharmacol. 2013;75:630\u2013636. doi: 10.1097/MEG.0b013e3283603e89.", "ArticleIdList": ["10.1097/MEG.0b013e3283603e89", "PMC3575930", "22831551"]}, {"Citation": "Teschke R., Frenzel C., Schulze J., Eickhoff A. Herbal hepatotoxicity: Challenges and pitfalls of causality assessment methods. World J. Gastroenterol. 2013;19:2864\u20132882. doi: 10.1097/MEG.0b013e3283603e89.", "ArticleIdList": ["10.1097/MEG.0b013e3283603e89", "PMC3660812", "23704820"]}, {"Citation": "Teschke R., Wolff A. Kava hepatotoxicity: Regulatory data selection and causality assessment. Dig. Liver Dis. 2009;41:891\u2013901. doi: 10.1016/j.dld.2009.04.003.", "ArticleIdList": ["10.1016/j.dld.2009.04.003", "19477698"]}, {"Citation": "Danan G., Teschke R. RUCAM in drug and herb induced liver injury: The update. Int. J. Mol. Sci. 2015;17 doi: 10.3390/ijms17010014.", "ArticleIdList": ["10.3390/ijms17010014", "PMC4730261", "26712744"]}, {"Citation": "Teschke R., Genthner A., Wolff A., Frenzel C., Schulze J., Eickhoff A. Herbal hepatotoxicity: Analysis of cases with initially reported positive re-exposure tests. Dig. Liver Dis. 2014;46:264\u2013269. doi: 10.1016/j.dld.2013.10.020.", "ArticleIdList": ["10.1016/j.dld.2013.10.020", "24315480"]}, {"Citation": "Showman A.F., Baker J.D., Linares C., Naeole C.K., Borris R., Johnston E., Konanui J., Turner H. Contemporary Pacific and Western perspectives onawa (Piper methysticum) toxicology. Fitoterapia. 2015;100:56\u201367. doi: 10.1016/j.fitote.2014.11.012.", "ArticleIdList": ["10.1016/j.fitote.2014.11.012", "25464054"]}, {"Citation": "Shimoda L.M., Park C., Stokes A.J., Gomes H.H., Turner H. Pacific island \u2032Awa (Kava) extracts, but not isolated kavalactones, promote proinflammatory responses in model mast cells. Phytother. Res. 2012;26:1934\u20131941. doi: 10.1002/ptr.4652.", "ArticleIdList": ["10.1002/ptr.4652", "PMC3773481", "22473598"]}, {"Citation": "Li X.Z., Ramzan I. Role of ethanol in kava hepatotoxicity. Phytother. Res. 2010;24:475\u2013480. doi: 10.1002/ptr.3046.", "ArticleIdList": ["10.1002/ptr.3046", "19943335"]}, {"Citation": "Faolex.  [(accessed on 19 December 2015)].  Available online:  http://faolex.fao.org/docs/html/van38473.htm."}, {"Citation": "Teschke R., Schulze J. Risk of kava hepatotoxicity and the FDA consumer advisory. JAMA. 2010;304:2174\u20132175. doi: 10.1001/jama.2010.1689.", "ArticleIdList": ["10.1001/jama.2010.1689", "21081732"]}, {"Citation": "Ehtpa.  [(accessed on 29 January 2015)].  Available online:  http://www.ehtpa.eu/pdf/EWG%20on%20Kava,%20Jul06.pdf."}, {"Citation": "Olsen L.R., Grillo M.P., Skonberg C. Constituents in kava extracts potentially involved in hepatotoxicity: A review. Chem. Res. Toxicol. 2011;24:992\u20131002. doi: 10.1021/tx100412m.", "ArticleIdList": ["10.1021/tx100412m", "21506562"]}, {"Citation": "Singh Y.N. Kava: An overview. J. Ethnopharmacol. 1992;37:13\u201345. doi: 10.1016/0378-8741(92)90003-A.", "ArticleIdList": ["10.1016/0378-8741(92)90003-A", "1453702"]}, {"Citation": "Moulds R.F., Malani J. Kava: Herbal panacea or liver poison? Med. J. Aust. 2003;178:451\u2013453.", "ArticleIdList": ["12720513"]}, {"Citation": "Mathews J.D., Riley M.D., Fejo L., Munoz E., Milns N.R., Gardner I.D., Powers J.R., Ganygulpa E., Gununuwawuy B.J. Effects of the heavy usage of kava on physical health: Summary of a pilot survey in an aboriginal community. Med. J. Aust. 1988;148:548\u2013555.", "ArticleIdList": ["3374423"]}, {"Citation": "Clough A.R., Jacups S.P., Wang Z., Burns C.B., Bailie R.S., Cairney S.J., Collie A., Guyula T., McDonald S.P., Currie B.J. Health effects of kava use in an eastern Arnhem Land Aboriginal community. Intern. Med. J. 2003;33:336\u2013340. doi: 10.1046/j.1444-0903.2003.00405.x.", "ArticleIdList": ["10.1046/j.1444-0903.2003.00405.x", "12895162"]}, {"Citation": "Young M.C., Fricker P.A., Thomson N.J., Lee K.A. Sudden death due to ischaemic heart disease in young aboriginal sportsmen in the Northern Territory, 1982\u20131996. Med. J. Aust. 1999;170:425\u2013428.", "ArticleIdList": ["10341774"]}, {"Citation": "Weeramanthri T., Spillane P., Currie B. Kava and Sudden Cardiac Death; Kava Research Workshop, Proceedings of a Workshop Convened by the Miwatj Health Aboriginal Corporation; Nhulunbuy, Australia. 10\u201311 May 1994."}, {"Citation": "Bilia A.R., Gallon S., Vincieri F.F. Kava-kava and anxiety: Growing knowledge about the efficacy and safety. Life Sci. 2002;70:2581\u20132597. doi: 10.1016/S0024-3205(02)01555-2.", "ArticleIdList": ["10.1016/S0024-3205(02)01555-2", "12269386"]}, {"Citation": "World Health Organization . Assessments of the Risk of Hepatotoxicity with Kava Products. WHO Document Production Services; Geneva, Switzerland: 2007."}, {"Citation": "Teschke R., Genthner A., Wolff A. Kava hepatotoxicity: Comparison of aqueous, ethanolic, acetonic kava extracts and kava-herbs mixtures. J. Ethnopharmacol. 2009;123:378\u2013384. doi: 10.1016/j.jep.2009.03.038.", "ArticleIdList": ["10.1016/j.jep.2009.03.038", "19501269"]}, {"Citation": "Teschke R., Sarris J., Lebot V. Kava hepatotoxicity solution: A six-point plan for new kava standardization. Phytomedicine. 2011;18:96\u2013103. doi: 10.1016/j.phymed.2010.10.002.", "ArticleIdList": ["10.1016/j.phymed.2010.10.002", "21112196"]}, {"Citation": "Teschke R., Sarris J., Schweitzer I. Kava hepatotoxicity in traditional and modern use: The presumed Pacific kava paradox hypothesis revisited. Br. J. Clin. Pharmacol. 2012;73:170\u2013174. doi: 10.1111/j.1365-2125.2011.04070.x.", "ArticleIdList": ["10.1111/j.1365-2125.2011.04070.x", "PMC3269575", "21801196"]}, {"Citation": "Ahpa.  [(accessed on 13 March 2016)].  Available online:  http://ventquery.com/1975428.html."}, {"Citation": "Lebot V. The Quality of Kava Consumed in the South Pacific.  [(accessed on 13 March 2016)];HerbalGram. 2006 71:34\u201337. Available online:  https://ewsd.wiv-isp.be/Publications%20on%20new%20psychoactive%20substances/Kava/Lebot2006_kava-quality-control.pdf."}, {"Citation": "Sorrentino L., Capasso A., Schmidt M. Safety of ethanolic kava extract: Results of a study of chronic toxicity in rats. Phytomedicine. 2006;13:542\u2013549. doi: 10.1016/j.phymed.2006.01.006.", "ArticleIdList": ["10.1016/j.phymed.2006.01.006", "16904878"]}, {"Citation": "Stickel F. Response to Aghdassi et al., Letter to the editor \u201cGenetic polymorphisms in the UDP-glucuronosyltransferase UGT1A7 gene in patients with acute liver failure after kava-kava consumption\u201d. Arch. Toxicol. 2015;489:2175\u20132176. doi: 10.1007/s00204-015-1612-8.", "ArticleIdList": ["10.1007/s00204-015-1612-8", "26475488"]}, {"Citation": "Strahl S., Ehret V., Dahm H.H., Maier K.P. Necrotizing hepatitis after taking herbal remedies. Dtsch. Med. Wochenschr. 1998;123:1410\u20131414. doi: 10.1055/s-2007-1024196.", "ArticleIdList": ["10.1055/s-2007-1024196", "9856112"]}, {"Citation": "FDA.  [(accessed on 19 December 2015)]; Available online:  http://www.fda.gov/Food/ResourcesForYou/Consumers/ucm085482.htm."}, {"Citation": "CDC.  [(accessed on 30 November 2015)]; Available online:  http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5147a1.htm."}, {"Citation": "Gazzetta Ufficiale.  [(accessed on 19 December 2015)].  Available online:  http://www.gazzettaufficiale.it/atto/vediMenuHTML;jsessionid=UQJ6BSGTdfr4T2No+AmHzg__.ntc-as1-guri2b?atto.dataPubblicazioneGazzetta=2002-06-18&atto.codiceRedazionale=02A07856&tipoSerie=serie_generale&tipoVigenza=originario."}, {"Citation": "Hassan Z., Muzaimi M., Navaratnam V., Yusoff N.H., Suhaimi F.W., Vadivelu R., Vicknasingam B.K., Amato D., von Horsten S., Ismail N.I., et al. From Kratom to mitragynine and its derivatives: Physiological and behavioural effects related to use, abuse, and addiction. Neurosci. Biobehav. Rev. 2013;37:138\u2013151. doi: 10.1016/j.neubiorev.2012.11.012.", "ArticleIdList": ["10.1016/j.neubiorev.2012.11.012", "23206666"]}, {"Citation": "Jansen K.L., Prast C.J. Ethnopharmacology of kratom and the Mitragyna alkaloids. J. Ethnopharmacol. 1988;23:115\u2013119. doi: 10.1016/0378-8741(88)90121-3.", "ArticleIdList": ["10.1016/0378-8741(88)90121-3", "3419199"]}, {"Citation": "Ingsathit A., Woratanarat P., Anukarahanonta T., Rattanasiri S., Chatchaipun P., Wattayakorn K., Lim S., Suriyawongpaisal P. Prevalence of psychoactive drug use among drivers in Thailand: A roadside survey. Accid. Anal. Prev. 2009;41:474\u2013478. doi: 10.1016/j.aap.2009.01.010.", "ArticleIdList": ["10.1016/j.aap.2009.01.010", "19393795"]}, {"Citation": "Maruyama T., Kawamura M., Kikura-Hanajiri R., Takayama H., Goda Y. The botanical origin of kratom (Mitragyna speciosa; Rubiaceae) available as abused drugs in the Japanese markets. J. Nat. Med. 2009;63:340\u2013344. doi: 10.1007/s11418-009-0325-9.", "ArticleIdList": ["10.1007/s11418-009-0325-9", "19294483"]}, {"Citation": "Adkins J.E., Boyer E.W., McCurdy C.R. Mitragyna speciosa, a psychoactive tree from Southeast Asia with opioid activity. Curr. Top. Med. Chem. 2011;11:1165\u20131175. doi: 10.2174/156802611795371305.", "ArticleIdList": ["10.2174/156802611795371305", "21050173"]}, {"Citation": "Warner M.L., Kaufman N.C., Grundmann O. The pharmacology and toxicology of kratom: From traditional herb to drug of abuse. Int. J. Legal Med. 2016;130:127\u2013138. doi: 10.1007/s00414-015-1279-y.", "ArticleIdList": ["10.1007/s00414-015-1279-y", "26511390"]}, {"Citation": "Shellard E.J. Ethnopharmacology of kratom and the Mitragyna alkaloids. J. Ethnopharmacol. 1989;25:123\u2013124. doi: 10.1016/0378-8741(89)90053-6.", "ArticleIdList": ["10.1016/0378-8741(89)90053-6", "2716343"]}, {"Citation": "Gong F., Gu H., Xu Q., Kang W. Genus Mitragyna: Ethnomedicinal uses and pharmacological studies. Phytopharmacology. 2012;3:263\u2013272."}, {"Citation": "Suwanlert S. A study of kratom eaters in Thailand. Bull. Narc. 1975;27:21\u201327.", "ArticleIdList": ["1041694"]}, {"Citation": "Vicknasingam B., Narayanan S., Beng G.T., Mansor S.M. The informal use of ketum (Mitragyna speciosa) for opioid withdrawal in the northern states of peninsular Malaysia and implications for drug substitution therapy. Int. J. Drug Policy. 2010;21:283\u2013288. doi: 10.1016/j.drugpo.2009.12.003.", "ArticleIdList": ["10.1016/j.drugpo.2009.12.003", "20092998"]}, {"Citation": "Prozialeck W.C., Jivan J.K., Andurkar S.V. Pharmacology of kratom: An emerging botanical agent with stimulant, analgesic and opioid-like effects. J. Am. Osteopath. Assoc. 2012;112:792\u2013799.", "ArticleIdList": ["23212430"]}, {"Citation": "Burkill I.H., Birtwistle W., Foxworthy F.W., Scrivenor J.B., Watson J.B. A Dictionary of the Economic Products of the Malay peninsula. Volume 2. Oxford University Press; London, UK: 1935. pp. 1480\u20131483."}, {"Citation": "Wray L. Biak: An opium substitute. J. Fed. Malay States Mus. 1907;2:53."}, {"Citation": "Harizal S.N., Mansor S.M., Hasnan J., Tharakan J.K., Abdullah J. Acute toxicity study of the standardized methanolic extract of Mitragyna speciosa Korth in rodent. J. Ethnopharmacol. 2010;131:404\u2013409. doi: 10.1016/j.jep.2010.07.013.", "ArticleIdList": ["10.1016/j.jep.2010.07.013", "20643198"]}, {"Citation": "Hillebrand J., Olszewski D., Sedefov R. Legal highs on the Internet. Subst. Use Misuse. 2010;45:330\u2013340. doi: 10.3109/10826080903443628.", "ArticleIdList": ["10.3109/10826080903443628", "20141450"]}, {"Citation": "Arndt T., Claussen U., Gussregen B., Schrofel S., Sturzer B., Werle A., Wolf G. Kratom alkaloids and O-desmethyltramadol in urine of a \u201cKrypton\u201d herbal mixture consumer. Forensic Sci. Int. 2011;208:47\u201352. doi: 10.1016/j.forsciint.2010.10.025.", "ArticleIdList": ["10.1016/j.forsciint.2010.10.025", "21112167"]}, {"Citation": "Ulbricht C., Costa D., Dao J., Isaac R., LeBlanc Y.C., Rhoades J., Windsor R.C. An evidence-based systematic review of kratom (Mitragyna speciosa) by the Natural Standard Research Collaboration. J. Diet. Suppl. 2013;10:152\u2013170. doi: 10.3109/19390211.2013.793541.", "ArticleIdList": ["10.3109/19390211.2013.793541", "23725528"]}, {"Citation": "Kronstrand R., Roman M., Thelander G., Eriksson A. Unintentional fatal intoxications with mitragynine and O-desmethyltramadol from the herbal blend Krypton. J. Anal. Toxicol. 2011;35:242\u2013247. doi: 10.1093/anatox/35.4.242.", "ArticleIdList": ["10.1093/anatox/35.4.242", "21513619"]}, {"Citation": "Tungtananuwat W., Lawanprasert S. Fatal 4 \u00d7 100; home-made kratom juice cocktail. J. Health Res. 2010;24:43\u201347."}, {"Citation": "Kowalczuk A.P., Lozak A., Zjawiony J.K. Comprehensive methodology for identification of Kratom in police laboratories. Forensic Sci. Int. 2013;233:238\u2013243. doi: 10.1016/j.forsciint.2013.09.016.", "ArticleIdList": ["10.1016/j.forsciint.2013.09.016", "24314525"]}, {"Citation": "Raffa R.B. Kratom and Other Mitragynines: The Chemistry and Pharmacology of Opioids from a Non-Opium Source. CRC Press Taylor & Francis Group; Boca Raton, FL, USA: 2014."}, {"Citation": "Sabetghadam A., Ramanathan S., Sasidharan S., Mansor S.M. Subchronic exposure to mitragynine, the principal alkaloid of Mitragyna speciosa, in rats. J. Ethnopharmacol. 2013;146:815\u2013823. doi: 10.1016/j.jep.2013.02.008.", "ArticleIdList": ["10.1016/j.jep.2013.02.008", "23422336"]}, {"Citation": "Kapp F.G., Maurer H.H., Auwarter V., Winkelmann M., Hermanns-Clausen M. Intrahepatic cholestasis following abuse of powdered kratom (Mitragyna speciosa) J. Med. Toxicol. 2011;7:227\u2013231. doi: 10.1007/s13181-011-0155-5.", "ArticleIdList": ["10.1007/s13181-011-0155-5", "PMC3550198", "21528385"]}, {"Citation": "Erowid.  [(accessed on 28 December 2015)].  Available online:  https://www.erowid.org/plants/kratom/kratom_health.shtml."}, {"Citation": "El-Menyar A., Mekkodathil A., Al-Thani H., Al-Motarreb A. Khat use: History and heart failure. Oman Med. J. 2015;30:77\u201382. doi: 10.5001/omj.2015.18.", "ArticleIdList": ["10.5001/omj.2015.18", "PMC4412450", "25960830"]}, {"Citation": "Patel N.B. \u201cNatural Amphetamine\u201d Khat: A cultural tradition or a drug of abuse? Int. Rev. Neurobiol. 2015;120:235\u2013255.", "ArticleIdList": ["26070760"]}, {"Citation": "Balint E.E., Falkay G., Balint G.A. Khat\u2014A controversial plant. Wien. Klin. Wochenschr. 2009;121:604\u2013614. doi: 10.1007/s00508-009-1259-7.", "ArticleIdList": ["10.1007/s00508-009-1259-7", "19921126"]}, {"Citation": "Toennes S.W., Harder S., Schramm M., Niess C., Kauert G.F. Pharmacokinetics of cathinone, cathine and norephedrine after the chewing of khat leaves. Br. J. Clin. Pharmacol. 2003;56:125\u2013130. doi: 10.1046/j.1365-2125.2003.01834.x.", "ArticleIdList": ["10.1046/j.1365-2125.2003.01834.x", "PMC1884326", "12848785"]}, {"Citation": "Murray C.D., Le Roux C.W., Emmanuel A.V., Halket J.M., Przyborowska A.M., Kamm M.A., Murray-Lyon I.M. The effect of Khat (Catha edulis) as an appetite suppressant is independent of ghrelin and PYY secretion. Appetite. 2008;51:747\u2013750. doi: 10.1016/j.appet.2008.06.012.", "ArticleIdList": ["10.1016/j.appet.2008.06.012", "18656509"]}, {"Citation": "Girma T., Mossie A., Getu Y. Association between body composition and khat chewing in Ethiopian adults. BMC Res. Notes. 2015;8:580. doi: 10.1186/s13104-015-1601-2.", "ArticleIdList": ["10.1186/s13104-015-1601-2", "PMC4650344", "26578211"]}, {"Citation": "Al-Habori M. The potential adverse effects of habitual use of Catha edulis (khat) Expert Opin. Drug Saf. 2005;4:1145\u20131154. doi: 10.1517/14740338.4.6.1145.", "ArticleIdList": ["10.1517/14740338.4.6.1145", "16255671"]}, {"Citation": "Pateria P., de Boer B., MacQuillan G. Liver abnormalities in drug and substance abusers. Best Pract. Res. Clin. Gastroenterol. 2013;27:577\u2013596. doi: 10.1016/j.bpg.2013.08.001.", "ArticleIdList": ["10.1016/j.bpg.2013.08.001", "24090944"]}, {"Citation": "Riyaz S., Imran M., Gleeson D., Karajeh M.A. Khat (Catha edulis) as a possible cause of autoimmune hepatitis. World J. Hepatol. 2014;6:150\u2013154. doi: 10.4254/wjh.v6.i3.150.", "ArticleIdList": ["10.4254/wjh.v6.i3.150", "PMC3959116", "24672645"]}, {"Citation": "Roelandt P., George C., d\u2019Heygere F., Aerts R., Monbaliu D., Laleman W., Cassiman D., Verslype C., van Steenbergen W., Pirenne J., et al. Acute liver failure secondary to khat (Catha edulis)-induced necrotic hepatitis requiring liver transplantation: Case report. Transpl. Proc. 2011;43:3493\u20133495. doi: 10.1016/j.transproceed.2011.09.032.", "ArticleIdList": ["10.1016/j.transproceed.2011.09.032", "22099826"]}, {"Citation": "Yildiz H., Komuta M., Monsalve C., Starkel P., Lefebvre C. To chew or not to chew: That\u2019s the question. Acta Clin. Belg. 2015 doi: 10.1179/2295333715Y.0000000070.", "ArticleIdList": ["10.1179/2295333715Y.0000000070", "26374255"]}, {"Citation": "Soboka M., Tesfaye M., Feyissa G.T., Hanlon C. Khat use in people living with HIV: A facility-based cross-sectional survey from South West Ethiopia. BMC Psychiatry. 2015;15:580. doi: 10.1186/s12888-015-0446-5.", "ArticleIdList": ["10.1186/s12888-015-0446-5", "PMC4394566", "25879767"]}, {"Citation": "Ketema T., Yohannes M., Alemayehu E., Ambelu A. Effect of chronic khat (Catha edulis, Forsk) use on outcome of Plasmodium berghei ANKA infection in Swiss albino mice. BMC Infect. Dis. 2015;15:580. doi: 10.1186/s12879-015-0911-2.", "ArticleIdList": ["10.1186/s12879-015-0911-2", "PMC4392739", "25886020"]}, {"Citation": "Ketema T., Bacha K., Alemayehu E., Ambelu A. Incidence of severe malaria syndromes and status of immune responses among Khat chewer Malaria patients in Ethiopia. PLoS ONE. 2015;10:580. doi: 10.1371/journal.pone.0131212.", "ArticleIdList": ["10.1371/journal.pone.0131212", "PMC4501669", "26173100"]}, {"Citation": "Teschke R., Qiu S.X., Lebot V. Herbal hepatotoxicity by kava: Update on pipermethystine, flavokavain B, and mould hepatotoxins as primarily assumed culprits. Dig. Liver Dis. 2011;43:676\u2013681. doi: 10.1016/j.dld.2011.01.018.", "ArticleIdList": ["10.1016/j.dld.2011.01.018", "21377431"]}, {"Citation": "Whitton P.A., Lau A., Salisbury A., Whitehouse J., Evans C.S. Kava lactones and the kava-kava controversy. Phytochemistry. 2003;64:673\u2013679. doi: 10.1016/S0031-9422(03)00381-9.", "ArticleIdList": ["10.1016/S0031-9422(03)00381-9", "13679089"]}, {"Citation": "Clouatre D.L. Kava kava: Examining new reports of toxicity. Toxicol. Lett. 2004;150:85\u201396. doi: 10.1016/j.toxlet.2003.07.005.", "ArticleIdList": ["10.1016/j.toxlet.2003.07.005", "15068826"]}, {"Citation": "Denham A., McIntyre M., Whitehouse J. Kava\u2014The unfolding story: Report on a work-in-progress. J. Altern. Complement. Med. 2002;8:237\u2013263. doi: 10.1089/10755530260127943.", "ArticleIdList": ["10.1089/10755530260127943", "12165183"]}, {"Citation": "Dragull K., Yoshida W.Y., Tang C.S. Piperidine alkaloids from Piper methysticum. Phytochemistry. 2003;63:193\u2013198. doi: 10.1016/S0031-9422(03)00111-0.", "ArticleIdList": ["10.1016/S0031-9422(03)00111-0", "12711141"]}, {"Citation": "Sim\u00e9oni P., Lebot V. Identification of factors determining kavalactones content and chemotype in Kava (Piper methysticum Forst. f.) Biochem. Syst. Ecol. 2002;30:413\u2013424. doi: 10.1016/S0305-1978(01)00093-X.", "ArticleIdList": ["10.1016/S0305-1978(01)00093-X"]}, {"Citation": "Rowe A., Zhang L.Y., Ramzan I. Toxicokinetics of kava. Adv. Pharmacol. Sci. 2011;2011 doi: 10.1155/2011/326724.", "ArticleIdList": ["10.1155/2011/326724", "PMC3085297", "21541070"]}, {"Citation": "Leon F., Habib E., Adkins J.E., Furr E.B., McCurdy C.R., Cutler S.J. Phytochemical characterization of the leaves of Mitragyna speciosa grown in U.S.A. Nat. Prod. Commun. 2009;4:907\u2013910.", "ArticleIdList": ["19731590"]}, {"Citation": "Takayama H. Chemistry and pharmacology of analgesic indole alkaloids from the rubiaceous plant, Mitragyna speciosa. Chem. Pharm. Bull. 2004;52:916\u2013928. doi: 10.1248/cpb.52.916.", "ArticleIdList": ["10.1248/cpb.52.916", "15304982"]}, {"Citation": "Matsumoto K., Horie S., Ishikawa H., Takayama H., Aimi N., Ponglux D., Watanabe K. Antinociceptive effect of 7-hydroxymitragynine in mice: Discovery of an orally active opioid analgesic from the Thai medicinal herb Mitragyna speciosa. Life Sci. 2004;74:2143\u20132155. doi: 10.1016/j.lfs.2003.09.054.", "ArticleIdList": ["10.1016/j.lfs.2003.09.054", "14969718"]}, {"Citation": "Hooper D. The anti-opium leaf. Pharm. J. 1907;78:453."}, {"Citation": "Zacharias D.E., Rosenstein R.D., Jeffrey E.A. The structure of mitragynine hydroiodide. Acta Crystallogr. 1965;18:1039\u20131043. doi: 10.1107/S0365110X65002499.", "ArticleIdList": ["10.1107/S0365110X65002499"]}, {"Citation": "Matsumoto K., Mizowaki M., Suchitra T., Takayama H., Sakai S., Aimi N., Watanabe H. Antinociceptive action of mitragynine in mice: Evidence for the involvement of supraspinal opioid receptors. Life Sci. 1996;59:1149\u20131155. doi: 10.1016/0024-3205(96)00432-8.", "ArticleIdList": ["10.1016/0024-3205(96)00432-8", "8831802"]}, {"Citation": "Watanabe K., Yano S., Horie S., Yamamoto L.T. Inhibitory effect of mitragynine, an alkaloid with analgesic effect from Thai medicinal plant Mitragyna speciosa, on electrically stimulated contraction of isolated guinea-pig ileum through the opioid receptor. Life Sci. 1997;60:933\u2013942. doi: 10.1016/S0024-3205(97)00023-4.", "ArticleIdList": ["10.1016/S0024-3205(97)00023-4", "9061050"]}, {"Citation": "Rosenbaum C.D., Carreiro S.P., Babu K.M. Here today, gone tomorrow...and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines. J. Med. Toxicol. 2012;8:15\u201332. doi: 10.1007/s13181-011-0202-2.", "ArticleIdList": ["10.1007/s13181-011-0202-2", "PMC3550220", "22271566"]}, {"Citation": "Matsumoto K., Hatori Y., Murayama T., Tashima K., Wongseripipatana S., Misawa K., Kitajima M., Takayama H., Horie S. Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa. Eur. J. Pharmacol. 2006;549:63\u201370. doi: 10.1016/j.ejphar.2006.08.013.", "ArticleIdList": ["10.1016/j.ejphar.2006.08.013", "16978601"]}, {"Citation": "Kitajima M., Misawa K., Kogure N., Said I.M., Horie S., Hatori Y., Murayama T., Takayama H. A new indole alkaloid, 7-hydroxyspeciociliatine, from the fruits of Malaysian Mitragyna speciosa and its opioid agonistic activity. J. Nat. Med. 2006;60:28\u201335. doi: 10.1007/s11418-005-0001-7.", "ArticleIdList": ["10.1007/s11418-005-0001-7"]}, {"Citation": "Erowid.  [(accessed on 2 January 2016)].  Available online:  https://www.erowid.org/plants/kratom/kratom_dose.shtml."}, {"Citation": "European Monitoring Center for Drugs and Drug Addiction.  [(accessed on 2 January 2016)].  Available online:  http://www.emcdda.europa.eu/publications/drug-profiles/kratom."}, {"Citation": "Matsumoto K., Horie S., Takayama H., Ishikawa H., Aimi N., Ponglux D., Murayama T., Watanabe K. Antinociception, tolerance and withdrawal symptoms induced by 7-hydroxymitragynine, an alkaloid from the Thai medicinal herb Mitragyna speciosa. Life Sci. 2005;78:2\u20137. doi: 10.1016/j.lfs.2004.10.086.", "ArticleIdList": ["10.1016/j.lfs.2004.10.086", "16169018"]}, {"Citation": "Kong W.M., Chik Z., Ramachandra M., Subramaniam U., Aziddin R.E., Mohamed Z. Evaluation of the effects of Mitragyna speciosa alkaloid extract on cytochrome P450 enzymes using a high throughput assay. Molecules. 2011;16:7344\u20137356. doi: 10.3390/molecules16097344.", "ArticleIdList": ["10.3390/molecules16097344", "PMC6264431", "21876481"]}, {"Citation": "Boyer E.W., Babu K.M., Adkins J.E., McCurdy C.R., Halpern J.H. Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa Korth) Addiction. 2008;103:1048\u20131050. doi: 10.1111/j.1360-0443.2008.02209.x.", "ArticleIdList": ["10.1111/j.1360-0443.2008.02209.x", "PMC3670991", "18482427"]}, {"Citation": "Holler J.M., Vorce S.P., McDonough-Bender P.C., Magluilo J., Jr., Solomon C.J., Levine B. A drug toxicity death involving propylhexedrine and mitragynine. J. Anal. Toxicol. 2011;35:54\u201359. doi: 10.1093/anatox/35.1.54.", "ArticleIdList": ["10.1093/anatox/35.1.54", "21219704"]}, {"Citation": "Nelsen J.L., Lapoint J., Hodgman M.J., Aldous K.M. Seizure and coma following Kratom (Mitragynina speciosa Korth) exposure. J. Med. Toxicol. 2010;6:424\u2013426. doi: 10.1007/s13181-010-0079-5.", "ArticleIdList": ["10.1007/s13181-010-0079-5", "PMC3550469", "20411370"]}, {"Citation": "Neerman M.F., Frost R.E., Deking J. A drug fatality involving Kratom. J. Forensic Sci. 2013;58(Suppl. S1):S278\u2013S279. doi: 10.1111/1556-4029.12009.", "ArticleIdList": ["10.1111/1556-4029.12009", "23082895"]}, {"Citation": "Dorman C., Wong M., Khan A. Cholestatic hepatitis from prolonged kratom use: A case report. Hepatology. 2015;61:1086\u20131087. doi: 10.1002/hep.27612.", "ArticleIdList": ["10.1002/hep.27612", "25418457"]}, {"Citation": "Kite G.C., Ismail M., Simmonds M.S., Houghton P.J. Use of doubly protonated molecules in the analysis of cathedulins in crude extracts of khat (Catha edulis) by liquid chromatography/serial mass spectrometry. Rapid Commun. Mass Spectrom. 2003;17:1553\u20131564. doi: 10.1002/rcm.1085.", "ArticleIdList": ["10.1002/rcm.1085", "12845580"]}, {"Citation": "Wabe N.T. Chemistry, pharmacology, and toxicology of khat (Catha edulis forsk): A review. Addict. Health. 2011;3:137\u2013149.", "ArticleIdList": ["PMC3905534", "24494129"]}, {"Citation": "Groves R.A., Hagel J.M., Zhang Y., Kilpatrick K., Levy A., Marsolais F., Lewinsohn E., Sensen C.W., Facchini P.J. Transcriptome profiling of khat (Catha edulis) and Ephedra sinica reveals gene candidates potentially involved in amphetamine-type alkaloid biosynthesis. PLoS ONE. 2015;10:580. doi: 10.1371/journal.pone.0119701.", "ArticleIdList": ["10.1371/journal.pone.0119701", "PMC4373857", "25806807"]}, {"Citation": "Hagel J.M., Krizevski R., Kilpatrick K., Sitrit Y., Marsolais F., Lewinsohn E., Facchini P.J. Expressed sequence tag analysis of khat (Catha edulis) provides a putative molecular biochemical basis for the biosynthesis of phenylpropylamino alkaloids. Genet. Mol. Biol. 2011;34:640\u2013646.", "ArticleIdList": ["PMC3229120", "22215969"]}, {"Citation": "Krizevski R., Dudai N., Bar E., Lewinsohn E. Developmental patterns of phenylpropylamino alkaloids accumulation in khat (Catha edulis, Forsk.) J. Ethnopharmacol. 2007;114:432\u2013438. doi: 10.1016/j.jep.2007.08.042.", "ArticleIdList": ["10.1016/j.jep.2007.08.042", "17928181"]}, {"Citation": "Kalix P., Braenden O. Pharmacological aspects of the chewing of khat leaves. Pharmacol. Rev. 1985;37:149\u2013164.", "ArticleIdList": ["2864707"]}, {"Citation": "UN . \u00c9tude s\u00fbr la Composition Chimique du Khat: Recherches s\u00fbr la Fraction Phenylalkylamine. United Nations; New York, NY, USA: 1975. UN Document MNAR/11/1975."}, {"Citation": "Russmann S., Barguil Y., Cabalion P., Kritsanida M., Duhet D., Lauterburg B.H. Hepatic injury due to traditional aqueous extracts of kava root in New Caledonia. Eur. J. Gastroenterol. Hepatol. 2003;15:1033\u20131036. doi: 10.1097/00042737-200309000-00015.", "ArticleIdList": ["10.1097/00042737-200309000-00015", "12923378"]}, {"Citation": "Rychetnik L., Madronio C.M. The health and social effects of drinking water-based infusions of kava: A review of the evidence. Drug Alcohol Rev. 2011;30:74\u201383. doi: 10.1111/j.1465-3362.2010.00184.x.", "ArticleIdList": ["10.1111/j.1465-3362.2010.00184.x", "21219501"]}, {"Citation": "Clough A. Enough! Or too much. What is \u201cexcessive\u201d kava use in Arnhem Land? Drug Alcohol Rev. 2003;22:43\u201351. doi: 10.1080/0959523021000059820.", "ArticleIdList": ["10.1080/0959523021000059820", "12745358"]}, {"Citation": "Brown A.C., Onopa J., Holck P., Kaufusi P., Kabasawa D., Craig W.J., Dragull K., Levine A.M., Baker J.D. Traditional kava beverage consumption and liver function tests in a predominantly Tongan population in Hawaii. Clin. Toxicol. 2007;45:549\u2013556. doi: 10.1080/15563650701365875.", "ArticleIdList": ["10.1080/15563650701365875", "17503265"]}, {"Citation": "Pittler M.H., Ernst E. Kava extract for treating anxiety. Cochrane Database Syst. Rev. 2003;195:CD003383.", "ArticleIdList": ["12535473"]}, {"Citation": "Sarris J., Kavanagh D.J., Byrne G., Bone K.M., Adams J., Deed G. The Kava Anxiety Depression Spectrum Study (KADSS): A randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticum. Psychopharmacology. 2009;205:399\u2013407. doi: 10.1007/s00213-009-1549-9.", "ArticleIdList": ["10.1007/s00213-009-1549-9", "19430766"]}, {"Citation": "Sarris J., Stough C., Teschke R., Wahid Z.T., Bousman C.A., Murray G., Savage K.M., Mouatt P., Ng C., Schweitzer I. Kava for the treatment of generalized anxiety disorder RCT: Analysis of adverse reactions, liver function, addiction, and sexual effects. Phytother. Res. 2013;27:1723\u20131728. doi: 10.1002/ptr.4916.", "ArticleIdList": ["10.1002/ptr.4916", "23348842"]}, {"Citation": "Nerurkar P.V., Dragull K., Tang C.S. In vitro toxicity of kava alkaloid, pipermethystine, in HepG2 cells compared to kavalactones. Toxicol. Sci. 2004;79:106\u2013111. doi: 10.1093/toxsci/kfh067.", "ArticleIdList": ["10.1093/toxsci/kfh067", "14737001"]}, {"Citation": "DiSilvestro R.A., Zhang W., DiSilvestro D.J. Kava feeding in rats does not cause liver injury nor enhance galactosamine-induced hepatitis. Food Chem. Toxicol. 2007;45:1293\u20131300. doi: 10.1016/j.fct.2007.01.015.", "ArticleIdList": ["10.1016/j.fct.2007.01.015", "17353074"]}, {"Citation": "Lechtenberg M., Quandt B., Schmidt M., Nahrstedt A. Is the alkaloid pipermethystine connected with the claimed liver toxicity of Kava products? Pharmazie. 2008;63:71\u201374.", "ArticleIdList": ["18271308"]}, {"Citation": "Tang J., Dunlop R.A., Rowe A., Rodgers K.J., Ramzan I. Kavalactones Yangonin and Methysticin induce apoptosis in human hepatocytes (HepG2) in vitro. Phytother. Res. 2011;25:417\u2013423. doi: 10.1002/ptr.3283.", "ArticleIdList": ["10.1002/ptr.3283", "20734326"]}, {"Citation": "Zhou P., Gross S., Liu J.H., Yu B.Y., Feng L.L., Nolta J., Sharma V., Piwnica-Worms D., Qiu S.X. Flavokawain B, the hepatotoxic constituent from kava root, induces GSH-sensitive oxidative stress through modulation of IKK/NF-\u03baB and MAPK signaling pathways. FASEB J. 2010;24:4722\u20134732. doi: 10.1096/fj.10-163311.", "ArticleIdList": ["10.1096/fj.10-163311", "PMC2992378", "20696856"]}, {"Citation": "Lude S., Torok M., Dieterle S., Jaggi R., Buter K.B., Krahenbuhl S. Hepatocellular toxicity of kava leaf and root extracts. Phytomedicine. 2008;15:120\u2013131. doi: 10.1016/j.phymed.2007.11.003.", "ArticleIdList": ["10.1016/j.phymed.2007.11.003", "18055189"]}, {"Citation": "Jhoo J.W., Freeman J.P., Heinze T.M., Moody J.D., Schnackenberg L.K., Beger R.D., Dragull K., Tang C.S., Ang C.Y. In vitro cytotoxicity of nonpolar constituents from different parts of kava plant (Piper methysticum) J. Agric. Food Chem. 2006;54:3157\u20133162. doi: 10.1021/jf051853j.", "ArticleIdList": ["10.1021/jf051853j", "16608246"]}, {"Citation": "Eskander R.N., Randall L.M., Sakai T., Guo Y., Hoang B., Zi X. Flavokawain B, a novel, naturally occurring chalcone, exhibits robust apoptotic effects and induces G2/M arrest of a uterine leiomyosarcoma cell line. J. Obstet. Gynaecol. Res. 2012;38:1086\u20131094. doi: 10.1111/j.1447-0756.2011.01841.x.", "ArticleIdList": ["10.1111/j.1447-0756.2011.01841.x", "PMC3405181", "22540374"]}, {"Citation": "Narayanapillai S.C., Leitzman P., O\u2019Sullivan M.G., Xing C. Flavokawains A and B in kava, not dihydromethysticin, potentiate acetaminophen-induced hepatotoxicity in C57BL/6 mice. Chem. Res. Toxicol. 2014;27:1871\u20131876. doi: 10.1021/tx5003194.", "ArticleIdList": ["10.1021/tx5003194", "PMC4203398", "25185080"]}, {"Citation": "Martin A.C., Johnston E., Xing C., Hegeman A.D. Measuring the chemical and cytotoxic variability of commercially available kava (Piper methysticum G. Forster) PLoS ONE. 2014;9:580. doi: 10.1371/journal.pone.0111572.", "ArticleIdList": ["10.1371/journal.pone.0111572", "PMC4218769", "25365244"]}, {"Citation": "Lebot V., Do T.K., Legendre L. Detection of flavokavins (A, B, C) in cultivars of kava (Piper methysticum) using high performance thin layer chromatography (HPTLC) Food Chem. 2014;151:554\u2013560. doi: 10.1016/j.foodchem.2013.11.120.", "ArticleIdList": ["10.1016/j.foodchem.2013.11.120", "24423570"]}, {"Citation": "Li X., Xu X., Ji T., Liu Z., Gu M., Hoang B.H., Zi X. Dietary feeding of Flavokawain A, a Kava chalcone, exhibits a satisfactory safety profile and its association with enhancement of phase II enzymes in mice. Toxicol. Rep. 2014;1:2\u201311.", "ArticleIdList": ["PMC4219529", "25379458"]}, {"Citation": "Singh Y.N., Devkota A.K. Aqueous kava extracts do not affect liver function tests in rats. Planta Med. 2003;69:496\u2013469.", "ArticleIdList": ["12865965"]}, {"Citation": "Clayton N.P., Yoshizawa K., Kissling G.E., Burka L.T., Chan P.C., Nyska A. Immunohistochemical analysis of expressions of hepatic cytochrome P450 in F344 rats following oral treatment with kava extract. Exp. Toxicol. Pathol. 2007;58:223\u2013236. doi: 10.1016/j.etp.2006.08.002.", "ArticleIdList": ["10.1016/j.etp.2006.08.002", "PMC1839869", "17059882"]}, {"Citation": "Mills S., Bone K.  The Essential Guide to Herbal Safety. Elsevier Inc.; Philadelphia, PA, USA: 2005.  [(accessed on 27 December 2015)].  Available online:  https://books.google.it/books?id=85M0N8UioCcC&pg=PA197&lpg=PA197&dq=is+kava+really+hepatotoxic?&source=bl&ots=nrZVROjep&sig=EEFj0MpPOFqvXTJu81BlwMB6jHA&hl=it&sa=X&ved=0ahUKEwjI6L2KlrvLAhXIVRQKHQA2DCwQ6AEINzAE#v=onepage&q=is%20kava%20really%20hepatotoxic%3F&f=false."}, {"Citation": "Unimuenster.  [(accessed on 22 December 2015)].  Available online:  http://www.uni-muenster.de/imperia/md/content/pharmazeutische_biologie/_v/review.pdf."}, {"Citation": "Whittaker P., Clarke J.J., San R.H., Betz J.M., Seifried H.E., de Jager L.S., Dunkel V.C. Evaluation of commercial kava extracts and kavalactone standards for mutagenicity and toxicity using the mammalian cell gene mutation assay in L5178Y mouse lymphoma cells. Food Chem. Toxicol. 2008;46:168\u2013174. doi: 10.1016/j.fct.2007.07.013.", "ArticleIdList": ["10.1016/j.fct.2007.07.013", "17822821"]}, {"Citation": "Behl M., Nyska A., Chhabra R.S., Travlos G.S., Fomby L.M., Sparrow B.R., Hejtmancik M.R., Chan P.C. Liver toxicity and carcinogenicity in F344/N rats and B6C3F1 mice exposed to Kava Kava. Food Chem. Toxicol. 2011;49:2820\u20132829. doi: 10.1016/j.fct.2011.07.067.", "ArticleIdList": ["10.1016/j.fct.2011.07.067", "PMC3190036", "21871523"]}, {"Citation": "National Toxicology Program Toxicology and carcinogenesis studies of kava kava extract (CAS No. 9000-38-8) in F344/N rats and B6C3F1 mice (Gavage Studies) Natl. Toxicol. Progr. Tech. Rep. Ser. 2012;571:1\u2013186.", "ArticleIdList": ["22441424"]}, {"Citation": "Yang X., Salminen W.F. Kava extract, an herbal alternative for anxiety relief, potentiates acetaminophen-induced cytotoxicity in rat hepatic cells. Phytomedicine. 2011;18:592\u2013600. doi: 10.1016/j.phymed.2011.02.006.", "ArticleIdList": ["10.1016/j.phymed.2011.02.006", "21397479"]}, {"Citation": "Lieber C.S., Abittan C.S. Pharmacology and metabolism of alcohol, including its metabolic effects and interactions with other drugs. Clin. Dermatol. 1999;17:365\u2013379. doi: 10.1016/S0738-081X(99)00020-6.", "ArticleIdList": ["10.1016/S0738-081X(99)00020-6", "10497719"]}, {"Citation": "Li A.P. A review of the common properties of drugs with idiosyncratic hepatotoxicity and the \u201cmultiple determinant hypothesis\u201d for the manifestation of idiosyncratic drug toxicity. Chem. Biol. Interact. 2002;142:7\u201323. doi: 10.1016/S0009-2797(02)00051-0.", "ArticleIdList": ["10.1016/S0009-2797(02)00051-0", "12399152"]}, {"Citation": "Duffield A.M., Jamieson D.D., Lidgard R.O., Duffield P.H., Bourne D.J. Identification of some human urinary metabolites of the intoxicating beverage kava. J. Chromatogr. 1989;475:273\u2013281. doi: 10.1016/S0021-9673(01)89682-5.", "ArticleIdList": ["10.1016/S0021-9673(01)89682-5", "2777959"]}, {"Citation": "Shen W.W. The metabolism of psychoactive drugs: A review of enzymatic biotransformation and inhibition. Biol. Psychiatry. 1997;41:814\u2013826. doi: 10.1016/S0006-3223(96)00180-1.", "ArticleIdList": ["10.1016/S0006-3223(96)00180-1", "9084901"]}, {"Citation": "Russmann S., Lauterburg B.H., Helbling A. Kava hepatotoxicity. Ann. Intern. Med. 2001;135:68\u201369. doi: 10.7326/0003-4819-135-1-200107030-00036.", "ArticleIdList": ["10.7326/0003-4819-135-1-200107030-00036", "11434754"]}, {"Citation": "Ingelman-Sundberg M. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): Clinical consequences, evolutionary aspects and functional diversity. Pharmacogenom. J. 2005;5:6\u201313. doi: 10.1038/sj.tpj.6500285.", "ArticleIdList": ["10.1038/sj.tpj.6500285", "15492763"]}, {"Citation": "Aghdassi A.A., Kraft M., Domschke W., Lerch M.M., Weiss F.U. Genetic polymorphisms in the UDP-glucuronosyltransferase UGT1A7 gene in patients with acute liver failure after kava-kava consumption. Arch. Toxicol. 2015;89:2173\u20132174. doi: 10.1007/s00204-015-1578-6.", "ArticleIdList": ["10.1007/s00204-015-1578-6", "26298863"]}, {"Citation": "Wu D., Yu L., Nair M.G., DeWitt D.L., Ramsewak R.S. Cyclooxygenase enzyme inhibitory compounds with antioxidant activities from Piper methysticum (kava kava) roots. Phytomedicine. 2002;9:41\u201347. doi: 10.1078/0944-7113-00068.", "ArticleIdList": ["10.1078/0944-7113-00068", "11924763"]}, {"Citation": "Raman P., Dewitt D.L., Nair M.G. Lipid peroxidation and cyclooxygenase enzyme inhibitory activities of acidic aqueous extracts of some dietary supplements. Phytother. Res. 2008;22:204\u2013212. doi: 10.1002/ptr.2287.", "ArticleIdList": ["10.1002/ptr.2287", "17726737"]}, {"Citation": "Mathews J.M., Etheridge A.S., Black S.R. Inhibition of human cytochrome P450 activities by kava extract and kavalactones. Drug Metab. Dispos. 2002;30:1153\u20131157. doi: 10.1124/dmd.30.11.1153.", "ArticleIdList": ["10.1124/dmd.30.11.1153", "12386118"]}, {"Citation": "Zou L., Henderson G.L., Harkey M.R., Sakai Y., Li A. Effects of kava (Kava-kava, \u2032Awa, Yaqona, Piper methysticum) on c-DNA-expressed cytochrome P450 enzymes and human cryopreserved hepatocytes. Phytomedicine. 2004;11:285\u2013294. doi: 10.1078/0944711041495263.", "ArticleIdList": ["10.1078/0944711041495263", "15185840"]}, {"Citation": "Cote C.S., Kor C., Cohen J., Auclair K. Composition and biological activity of traditional and commercial kava extracts. Biochem. Biophys. Res. Commun. 2004;322:147\u2013152. doi: 10.1016/j.bbrc.2004.07.093.", "ArticleIdList": ["10.1016/j.bbrc.2004.07.093", "15313185"]}, {"Citation": "Mathews J.M., Etheridge A.S., Valentine J.L., Black S.R., Coleman D.P., Patel P., So J., Burka L.T. Pharmacokinetics and disposition of the kavalactone kawain: Interaction with kava extract and kavalactones in vivo and in vitro. Drug Metab. Dispos. 2005;33:1555\u20131563. doi: 10.1124/dmd.105.004317.", "ArticleIdList": ["10.1124/dmd.105.004317", "16033948"]}, {"Citation": "Lim S.T., Dragull K., Tang C.S., Bittenbender H.C., Efird J.T., Nerurkar P.V. Effects of kava alkaloid, pipermethystine, and kavalactones on oxidative stress and cytochrome P450 in F-344 rats. Toxicol. Sci. 2007;97:214\u2013221. doi: 10.1093/toxsci/kfm035.", "ArticleIdList": ["10.1093/toxsci/kfm035", "17329236"]}, {"Citation": "Guo L., Li Q., Xia Q., Dial S., Chan P.C., Fu P. Analysis of gene expression changes of drug metabolizing enzymes in the livers of F344 rats following oral treatment with kava extract. Food Chem. Toxicol. 2009;47:433\u2013442. doi: 10.1016/j.fct.2008.11.037.", "ArticleIdList": ["10.1016/j.fct.2008.11.037", "PMC5744584", "19100306"]}, {"Citation": "Yamazaki Y., Hashida H., Arita A., Hamaguchi K., Shimura F. High dose of commercial products of kava (Piper methysticum) markedly enhanced hepatic cytochrome P450 1A1 mRNA expression with liver enlargement in rats. Food Chem. Toxicol. 2008;46:3732\u20133738. doi: 10.1016/j.fct.2008.09.052.", "ArticleIdList": ["10.1016/j.fct.2008.09.052", "18930106"]}, {"Citation": "Guo L., Shi Q., Dial S., Xia Q., Mei N., Li Q.Z., Chan P.C., Fu P. Gene expression profiling in male B6C3F1 mouse livers exposed to kava identifies\u2014Changes in drug metabolizing genes and potential mechanisms linked to kava toxicity. Food Chem. Toxicol. 2010;48:686\u2013696. doi: 10.1016/j.fct.2009.11.050.", "ArticleIdList": ["10.1016/j.fct.2009.11.050", "PMC2918424", "19948201"]}, {"Citation": "Zou L., Harkey M.R., Henderson G.L. Synthesis, in vitro, reactivity, and identification of 6-phenyl-3-hexen-2-one in human urine after kava-kava (Piper methysticum) ingestion. Planta Med. 2005;71:142\u2013146. doi: 10.1055/s-2005-837781.", "ArticleIdList": ["10.1055/s-2005-837781", "15729622"]}, {"Citation": "Johnson B.M., Qiu S.X., Zhang S., Zhang F., Burdette J.E., Yu L., Bolton J.L., van Breemen R.B. Identification of novel electrophilic metabolites of Piper methysticum Forst (Kava) Chem. Res. Toxicol. 2003;16:733\u2013740. doi: 10.1021/tx020113r.", "ArticleIdList": ["10.1021/tx020113r", "12807356"]}, {"Citation": "Zenger K., Agnolet S., Schneider B., Kraus B. Biotransformation of Flavokawains A, B, and C, Chalcones from Kava (Piper methysticum), by Human Liver Microsomes. J. Agric. Food Chem. 2015;63:6376\u20136385. doi: 10.1021/acs.jafc.5b01858.", "ArticleIdList": ["10.1021/acs.jafc.5b01858", "26123050"]}, {"Citation": "Rowe A., Ramzan I. Are mould hepatotoxins responsible for kava hepatotoxicity? Phytother. Res. 2012;26:1768\u20131770. doi: 10.1002/ptr.4620.", "ArticleIdList": ["10.1002/ptr.4620", "22319018"]}, {"Citation": "Teschke R., Sarris J., Lebot V. Contaminant hepatotoxins as culprits for kava hepatotoxicity\u2014Fact or fiction? Phytother. Res. 2013;27:472\u2013474. doi: 10.1002/ptr.4729.", "ArticleIdList": ["10.1002/ptr.4729", "22585547"]}, {"Citation": "Zhang L.Y., Rowe A., Ramzan I. Does inflammation play a role in kava hepatotoxicity? Phytother. Res. 2011;25:629\u2013630.", "ArticleIdList": ["20842679"]}, {"Citation": "Zhang L., Rowe A., Braet F., Ramzan I. Macrophage depletion ameliorates kavalactone damage in the isolated perfused rat liver. J. Toxicol. Sci. 2012;37:447\u2013453. doi: 10.2131/jts.37.447.", "ArticleIdList": ["10.2131/jts.37.447", "22467036"]}, {"Citation": "Gow P.J., Connelly N.J., Hill R.L., Crowley P., Angus P.W. Fatal fulminant hepatic failure induced by a natural therapy containing kava. Med. J. Aust. 2003;178:442\u2013443.", "ArticleIdList": ["12720510"]}, {"Citation": "Escher M., Desmeules J., Giostra E., Mentha G. Hepatitis associated with Kava, a herbal remedy for anxiety. BMJ. 2001;322:1097. doi: 10.1136/bmj.322.7279.139.", "ArticleIdList": ["10.1136/bmj.322.7279.139", "PMC26591", "11159570"]}, {"Citation": "Campo J.V., McNabb J., Perel J.M., Mazariegos G.V., Hasegawa S.L., Reyes J. Kava-induced fulminant hepatic failure. J. Am. Acad. Child Adolesc. Psychiatry. 2002;41:631\u2013632. doi: 10.1097/00004583-200206000-00001.", "ArticleIdList": ["10.1097/00004583-200206000-00001", "12049436"]}, {"Citation": "Estes J.D., Stolpman D., Olyaei A., Corless C.L., Ham J.M., Schwartz J.M., Orloff S.L. High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure. Arch. Surg. 2003;138:852\u2013858. doi: 10.1001/archsurg.138.8.852.", "ArticleIdList": ["10.1001/archsurg.138.8.852", "12912743"]}, {"Citation": "Stickel F., Baumuller H.M., Seitz K., Vasilakis D., Seitz G., Seitz H.K., Schuppan D. Hepatitis induced by Kava (Piper methysticum rhizoma) J. Hepatol. 2003;39:62\u201367. doi: 10.1016/S0168-8278(03)00175-2.", "ArticleIdList": ["10.1016/S0168-8278(03)00175-2", "12821045"]}, {"Citation": "Humberston C.L., Akhtar J., Krenzelok E.P. Acute hepatitis induced by kava kava. J. Toxicol. Clin. Toxicol. 2003;41:109\u2013113. doi: 10.1081/CLT-120019123.", "ArticleIdList": ["10.1081/CLT-120019123", "12733846"]}, {"Citation": "Teschke R., Gaus W., Loew D. Kava extracts: Safety and risks including rare hepatotoxicity. Phytomedicine. 2003;10:440\u2013446. doi: 10.1078/0944-7113-00314.", "ArticleIdList": ["10.1078/0944-7113-00314", "12834011"]}, {"Citation": "Christl S.U., Seifert A., Seeler D. Toxic hepatitis after consumption of traditional kava preparation. J. Travel Med. 2009;16:55\u201356. doi: 10.1111/j.1708-8305.2008.00259.x.", "ArticleIdList": ["10.1111/j.1708-8305.2008.00259.x", "19192130"]}, {"Citation": "Scribd.  [(accessed on 4 January 2016)].  Available online:  http://www.scribd.com/doc/46179789/Cytotoxicity-of-Extract-of-Malaysian-Mitragyna-Speciosa-Korth-and-Its-Dominant-Alkaloid Mitragynine#scribd."}, {"Citation": "Moklas M.A.M., Nurul Raudzah A.R., Taufik Hidayat M., Sharida F., Farah Idayu N., Zulkhairi A., Shamima A.R. A preliminary toxicity study of mitragynine, an alkaloid from Mitragyna speciosa Korth and its effects on locomotor activity in rats. Adv. Med. Dent. Sci. 2008;2:56\u201360."}, {"Citation": "Ghazali A.R., Abdullah R., Ramli N., Rajab N.F., Ahmad-Kamal M.S., Yahya N.A. Mutagenic and antimutagenic activities of Mitragyna speciosa Korth extract using Ames test. J. Med. Plants Res. 2011;5:1345\u20131348."}, {"Citation": "Macko E., Weisbach J.A., Douglas B. Some observations on the pharmacology of mitragynine. Arch. Int. Pharmacodyn. Ther. 1972;198:145\u2013161.", "ArticleIdList": ["4626477"]}, {"Citation": "De Moraes N.V., Moretti R.A., Furr E.B., 3rd, McCurdy C.R., Lanchote V.L. Determination of mitragynine in rat plasma by LC-MS/MS: Application to pharmacokinetics. J. Chromatogr. B. 2009;877:2593\u20132597. doi: 10.1016/j.jchromb.2009.06.023.", "ArticleIdList": ["10.1016/j.jchromb.2009.06.023", "19589735"]}, {"Citation": "Janchawee B., Keawpradub N., Chittrakarn S., Prasettho S., Wararatananurak P., Sawangjareon K. A high-performance liquid chromatographic method for determination of mitragynine in serum and its application to a pharmacokinetic study in rats. Biomed. Chromatogr. 2007;21:176\u2013183. doi: 10.1002/bmc.731.", "ArticleIdList": ["10.1002/bmc.731", "17221920"]}, {"Citation": "Azizi J., Ismail S., Mordi M.N., Ramanathan S., Said M.I., Mansor S.M. In vitro and in vivo effects of three different Mitragyna speciosa korth leaf extracts on phase II drug metabolizing enzymes\u2014Glutathione transferases (GSTs) Molecules. 2010;15:432\u2013441. doi: 10.3390/molecules15010432.", "ArticleIdList": ["10.3390/molecules15010432", "PMC6256986", "20110902"]}, {"Citation": "Kalix P. Khat, an amphetamine-like stimulant. J. Psychoact. Drugs. 1994;26:69\u201374. doi: 10.1080/02791072.1994.10472604.", "ArticleIdList": ["10.1080/02791072.1994.10472604", "7913130"]}, {"Citation": "Nencini P., Ahmed A.M. Khat consumption: A pharmacological review. Drug Alcohol Depend. 1989;23:19\u201329. doi: 10.1016/0376-8716(89)90029-X.", "ArticleIdList": ["10.1016/0376-8716(89)90029-X", "2537717"]}, {"Citation": "Chapman M.H., Kajihara M., Borges G., O\u2019Beirne J., Patch D., Dhillon A.P., Crozier A., Morgan M.Y. Severe, acute liver injury and khat leaves. N. Engl. J. Med. 2010;362:1642\u20131644. doi: 10.1056/NEJMc0908038.", "ArticleIdList": ["10.1056/NEJMc0908038", "20427816"]}, {"Citation": "Abid M.D., Chen J., Xiang M., Zhou J., Chen X., Gong F. Khat (Catha edulis) generates reactive oxygen species and promotes hepatic cell apoptosis via MAPK activation. Int. J. Mol. Med. 2013;32:389\u2013395.", "ArticleIdList": ["23708648"]}, {"Citation": "Aklillu E., Herrlin K., Gustafsson L.L., Bertilsson L., Ingelman-Sundberg M. Evidence for environmental influence on CYP2D6-catalysed debrisoquine hydroxylation as demonstrated by phenotyping and genotyping of Ethiopians living in Ethiopia or in Sweden. Pharmacogenetics. 2002;12:375\u2013383. doi: 10.1097/00008571-200207000-00005.", "ArticleIdList": ["10.1097/00008571-200207000-00005", "12142727"]}, {"Citation": "Cascorbi I. Pharmacogenetics of cytochrome p4502D6: Genetic background and clinical implication. Eur. J. Clin. Investig. 2003;33(Suppl. S2):17\u201322. doi: 10.1046/j.1365-2362.33.s2.3.x.", "ArticleIdList": ["10.1046/j.1365-2362.33.s2.3.x", "14641552"]}, {"Citation": "Pedersen A.J., Reitzel L.A., Johansen S.S., Linnet K. In vitro metabolism studies on mephedrone and analysis of forensic cases. Drug Test. Anal. 2013;5:430\u2013438. doi: 10.1002/dta.1369.", "ArticleIdList": ["10.1002/dta.1369", "22573603"]}, {"Citation": "Pedersen A.J., Petersen T.H., Linnet K. In vitro metabolism and pharmacokinetic studies on methylone. Drug Metab. Dispos. 2013;41:1247\u20131255. doi: 10.1124/dmd.112.050880.", "ArticleIdList": ["10.1124/dmd.112.050880", "23545806"]}, {"Citation": "Bedada W., de Andres F., Engidawork E., Pohanka A., Beck O., Bertilsson L., Llerena A., Aklillu E. The Psychostimulant khat (Catha edulis) Inhibits CYP2D6 enzyme activity in humans. J. Clin. Psychopharmacol. 2015;35:694\u2013699. doi: 10.1097/JCP.0000000000000413.", "ArticleIdList": ["10.1097/JCP.0000000000000413", "26444948"]}, {"Citation": "Teschke R. Kava hepatotoxicity: Pathogenetic aspects and prospective considerations. Liver Int. 2010;30:1270\u20131279. doi: 10.1111/j.1478-3231.2010.02308.x.", "ArticleIdList": ["10.1111/j.1478-3231.2010.02308.x", "20630022"]}, {"Citation": "Kuchta K., Schmidt M., Nahrstedt A. German kava ban lifted by court: The alleged hepatotoxicity of kava (Piper methysticum) as a case of ill-defined herbal drug identity, lacking quality control, and misguided regulatory politics. Planta Med. 2015;81:1647\u20131653. doi: 10.1055/s-0035-1558295.", "ArticleIdList": ["10.1055/s-0035-1558295", "26695707"]}, {"Citation": "Herbalgram.  [(accessed on 13 March 2016)].  Available online:  http://cms.herbalgram.org/heg/volume11/07July/GermanKavaBanReversal.html?ts=1457796407&signature=f5ff90a5a274ae67fa1fc62f1ed7ee40%3Cspan&ts=1458062348&signature=91d4418f692013ef2178b44d285f2169."}, {"Citation": "Savage K.M., Stough C.K., Byrne G.J., Scholey A., Bousman C., Murphy J., Macdonald P., Suo C., Hughes M., Thomas S., et al. Kava for the treatment of generalised anxiety disorder (K-GAD): Study protocol for a randomised controlled trial. Trials. 2015;16 doi: 10.1186/s13063-015-0986-5.", "ArticleIdList": ["10.1186/s13063-015-0986-5", "PMC4630875", "26527536"]}], "ReferenceList": []}], "History": [{"Year": "2016", "Month": "2", "Day": "18"}, {"Year": "2016", "Month": "2", "Day": "18"}, {"Year": "2016", "Month": "4", "Day": "11"}, {"Year": "2016", "Month": "4", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "4", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "1", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "4", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["27092496", "PMC4849036", "10.3390/ijms17040580", "ijms17040580"]}}], "PubmedBookArticle": []}